Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAMA Otolaryngology-- Head & Neck Surgery|May 30, 2024
Vascular Endothelial Growth Factor Receptor Inhibitors for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Systematic Review and Meta-AnalysisCamilla O Hoff, Joao Manzi, Felippe Lazar Neto, et al.
Cancers|June 10, 2023
Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future PerspectivesJoao Manzi, Camilla O Hoff, Raphaella Ferreira, et al.
Critical Reviews in Oncology/Hematology|August 17, 2024
A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasmsCamilla O Hoff, Joao Manzi, Raphaella Ferreira, et al.
JCO Precision Oncology|April 5, 2024
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case ReportCamilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, et al.
Cancers|June 28, 2023
Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver TransplantJoao Manzi, Camilla O Hoff, Raphaella Ferreira, et al.
Cancer Medicine|March 3, 2025
Clinical Outcomes With Notch Inhibitors in Notch-Activated Recurrent/Metastatic Adenoid Cystic CarcinomaCamilla O Hoff, Luana G de Sousa, Flavia Bonini, et al.
Cancer|May 16, 2025
Survival outcomes of pulmonary metastasis-directed local therapy in adenoid cystic carcinomaCamilla O Hoff, Lei Feng, Flavia Bonini, et al.
Oral Oncology|March 20, 2024
Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinomaEduardo A Dal Lago, Luana G Sousa, Zixi Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II TrialCamilla O Hoff, Simon Heeke, Yoshitsugu Mitani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell CarcinomaKevin J Contrera, Renata Ferrarotto, Brandon Gunn, et al.
Pageof 1